XML 13 R6.htm IDEA: XBRL DOCUMENT v3.24.1.u1
UNAUDITED CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
3 Months Ended 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Dec. 31, 2023
Operating activities:      
Net loss $ (13,357) $ (14,719)  
Adjustments to reconcile net loss to net cash provided by operating activities:      
(Recovery) provision for credit loss (886) 444 $ 3,142
Depreciation and amortization 11,653 10,555  
Amortization of right-of-use asset 2,625 2,491  
Stock-based compensation expense 11,272 13,035  
Fair value changes in financial instruments (297) 1,873  
Fair value changes in business acquisition contingencies 106 (398)  
Deferred income taxes (414) 1,367  
Other (91) 458  
Changes in operating assets and liabilities, net of acquisitions:      
Accounts receivable and contract assets (9,093) 9,615  
Prepaid expenses and other current assets (2,538) (3,363)  
Accounts payable and other accrued liabilities (7,824) (11,643)  
Accrued payroll and benefits (10,000) (4,350)  
Change in operating leases (3,177) (2,336)  
Net cash (used in) provided by operating activities (22,021) 3,029  
Investing activities:      
Proceeds from corporate owned and property insurance 40 75  
Purchases of property and equipment (5,979) (4,134)  
Proprietary software development and other software costs (1,300) (638)  
Purchase price true ups 320 (505)  
Cash paid for acquisitions, net of cash acquired (58,119) (6,525)  
Net cash used in investing activities (65,038) (11,727)  
Financing activities:      
Proceeds from line of credit 166,995    
Repayment of the line of credit (78,799)    
Repayment of aircraft loan (261)    
Proceeds from term loan 50,000    
Repayment of term loan (3,281) (2,188)  
Payment of contingent consideration and other purchase price true ups (363) (27)  
Repayment of finance leases (1,083) (1,029)  
Payments of deferred financing costs (348)    
Proceeds from issuance of common stock for exercised stock options 487 2,690  
Dividend payment to the series A-2 stockholders   (4,100)  
Repayment to the series A-2 stockholders (60,000)    
Net cash provided by (used in) financing activities 73,347 (4,654)  
Change in cash, cash equivalents and restricted cash (13,712) (13,352)  
Foreign exchange impact on cash balance (42) 318  
Cash, cash equivalents and restricted cash:      
Beginning of year 23,240 89,828 89,828
End of period 9,486 76,794 $ 23,240
Supplemental disclosures of cash flows information:      
Cash paid for interest 3,098 1,347  
Cash paid for income tax 292 155  
Supplemental disclosures of non-cash investing and financing activities:      
Accrued purchases of property and equipment 163 3,096  
Property and equipment purchased under finance leases 2,058 2,405  
Common stock issued to acquire new businesses 6,580    
Acquisitions unpaid contingent consideration 40,461 $ 7,855  
Accrued dividend payment 2,814    
Acquisitions contingent consideration paid in common stock $ 1,087